Join us for the xMAP® Connect 2026 Virtual Series, a three-part event designed to explore the capabilities and applications of xMAP® multiplexing technology. This virtual program brings together experts and researchers to share perspectives on assay development, biomarker analysis, and diagnostic approaches in a flexible online format.
Discover more about the event and register here.
Session Dates
- July 15, 2026
- September 9, 2026
- November 4, 2026
Time (all sessions)
Program Overview
This three-session series will address key topics across the multiplexing workflow and its application in research and clinical settings:
- July 15 – Getting Started with to xMAP® Multiplexing
- September 9 – Vaccine Development and Clinical Trials
- November 4 – Cytokine Research with xMAP® Multiplexing
Participants in this series will have the opportunity to:
- Discover the power of Luminex xMAP® Technology and why it’s the leading platform for analyzing biomarkers and immunogenicity.
- Learn from xMAP® experts who specialize in the validation, optimization, and development of multiplex assays for nucleic acids and proteins.
- Gain insights into how researchers have efficiently developed biomarker assays to support clinical trials using xMAP Technology.
- Explore how xMAP could be the ideal technology to develop your innovative diagnostic test.
- Understand the best practices across a wide range of research applications.
The series will feature contributions from Luminex Global Partners, including Thermo Fisher Scientific, MilliporeSigma, and Bio-Techne. Speakers will provide updates on emerging biomarker targets and related assay developments.
Designed as a virtual program, this event is intended for researchers, scientists, and laboratory professionals interested in multiplexing technologies, including both new and experienced users.
